168 related articles for article (PubMed ID: 1370872)
1. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.
Mazumdar S; Das KM
Am J Gastroenterol; 1992 Feb; 87(2):176-81. PubMed ID: 1370872
[TBL] [Abstract][Full Text] [Related]
2. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
3. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the peptidergic nerves (substance P and vasoactive intestinal peptide) in the colon of women patients with slow transit constipation: an in vitro study.
Tomita R
Hepatogastroenterology; 2008; 55(82-83):500-7. PubMed ID: 18613396
[TBL] [Abstract][Full Text] [Related]
5. Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.
ter Beek WP; Muller ES; Van Hogezand RA; Biemond I; Lamers CB
J Clin Pathol; 2004 Oct; 57(10):1047-51. PubMed ID: 15452158
[TBL] [Abstract][Full Text] [Related]
6. Distribution of substance P and vasoactive intestinal peptide in the human liver: light and electron immunoperoxidase methods of observation.
Ueno T; Inuzuka S; Torimura T; Sakata R; Sakamoto M; Gondo K; Aoki T; Tanikawa K; Tsutsumi V
Am J Gastroenterol; 1991 Nov; 86(11):1633-7. PubMed ID: 1719804
[TBL] [Abstract][Full Text] [Related]
7. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease.
Bernstein CN; Robert ME; Eysselein VE
Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884
[TBL] [Abstract][Full Text] [Related]
8. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
9. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
[TBL] [Abstract][Full Text] [Related]
10. Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease.
Wallengren J; Ekman R; Möller H
Acta Derm Venereol; 1986; 66(1):23-8. PubMed ID: 2424210
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease.
Bishop AE; Polak JM; Bryant MG; Bloom SR; Hamilton S
Gastroenterology; 1980 Nov; 79(5 Pt 1):853-60. PubMed ID: 7419008
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.
Andoh A; Deguchi Y; Inatomi O; Yagi Y; Bamba S; Tsujikawa T; Fujiyama Y
Oncol Rep; 2006 Jul; 16(1):103-7. PubMed ID: 16786130
[TBL] [Abstract][Full Text] [Related]
15. Distribution of vasoactive intestinal peptide- and substance P-containing nerves originating from neurons of airway ganglia in cat bronchi.
Dey RD; Altemus JB; Michalkiewicz M
J Comp Neurol; 1991 Feb; 304(2):330-40. PubMed ID: 1707900
[TBL] [Abstract][Full Text] [Related]
16. Expression of neuropeptides in normal and abnormal appendices.
Bouchard S; Russo P; Radu AP; Adzick NS
J Pediatr Surg; 2001 Aug; 36(8):1222-6. PubMed ID: 11479861
[TBL] [Abstract][Full Text] [Related]
17. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
ter Beek WP; Biemond I; Muller ES; van den Berg M; Lamers CB
Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
[TBL] [Abstract][Full Text] [Related]
18. Preliminary immunohistochemical new findings in the myenteric plexus of patients with intestinal neuronal dysplasia type B.
Munakata K; Tomita R; Kurosu Y
Eur J Pediatr Surg; 1997 Feb; 7(1):21-9. PubMed ID: 9085804
[TBL] [Abstract][Full Text] [Related]
19. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of neurohormonal peptides, serotonin, and nitric oxide synthase in the gastrointestinal neuroendocrine system of the axolotl (Ambystoma mexicanum): an immunohistochemical analysis.
Maake C; Kaufmann C; Reinecke M
Gen Comp Endocrinol; 2001 Jan; 121(1):74-83. PubMed ID: 11161772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
